We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-17.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10B
AUM Growth
-$4.54B
Cap. Flow
-$1.63B
Cap. Flow %
-16.3%
Top 10 Hldgs %
18.24%
Holding
2,308
New
654
Increased
395
Reduced
491
Closed
723

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$173M
2
EBAY icon
eBay
EBAY
+$149M
3
ZTS icon
Zoetis
ZTS
+$127M
4
TFX icon
Teleflex
TFX
+$108M
5
TMO icon
Thermo Fisher Scientific
TMO
+$98.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.96%
2 Consumer Discretionary 18.46%
3 Technology 13.47%
4 Financials 11.57%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMC icon
401
Vulcan Materials
VMC
$37.2B
$4.64M 0.05%
42,952
-75,025
-64% -$9.58M
BMTX
402
DELISTED
BM Technologies, Inc.
BMTX
$4.63M 0.05%
450,000
AEP icon
403
American Electric Power
AEP
$73.5B
$4.63M 0.05%
57,858
-90,068
-61% -$8.52M
MGNI icon
404
Magnite
MGNI
$2.72B
$4.63M 0.05%
833,430
+234,015
+39% +$2.15M
ZEN
405
DELISTED
ZENDESK INC
ZEN
$4.62M 0.05%
72,097
+61,355
+571% +$4.79M
ICFI icon
406
ICF International
ICFI
$1.47B
$4.56M 0.05%
+66,409
New +$5.42M
MTX icon
407
Minerals Technologies
MTX
$2.34B
$4.56M 0.05%
125,827
+68,974
+121% +$3.34M
DRNA
408
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4.55M 0.05%
247,695
-732,175
-75% -$14.2M
IOSP icon
409
Innospec
IOSP
$2.09B
$4.5M 0.05%
+64,829
New +$5.92M
AMPH icon
410
Amphastar Pharmaceuticals
AMPH
$843M
$4.48M 0.04%
301,910
+7,846
+3% +$137K
USFD icon
411
US Foods
USFD
$21.7B
$4.46M 0.04%
251,851
-708,987
-74% -$23.7M
TPH
412
DELISTED
Tri Pointe Homes
TPH
$4.44M 0.04%
505,973
-297,046
-37% -$4.34M
META icon
413
Meta Platforms (Facebook)
META
$1.54T
$4.43M 0.04%
26,580
-238,418
-90% -$46.7M
GPI icon
414
Group 1 Automotive
GPI
$4.07B
$4.39M 0.04%
99,183
+25,553
+35% +$2.15M
UHS icon
415
Universal Health Services
UHS
$9.64B
$4.38M 0.04%
44,193
-55,221
-56% -$6.99M
FFIV icon
416
F5
FFIV
$22.5B
$4.35M 0.04%
+40,830
New +$4.99M
SKIL icon
417
Skillsoft
SKIL
$56.5M
$4.34M 0.04%
21,823
-13,177
-38% -$2.76M
WKC icon
418
World Kinect Corp
WKC
$1.96B
$4.33M 0.04%
172,031
-20,556
-11% -$701K
FTSV
419
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$4.32M 0.04%
+45,244
New +$2.74M
NSTG
420
DELISTED
NanoString Technologies, Inc.
NSTG
$4.29M 0.04%
+178,365
New +$5.16M
ADV icon
421
Advantage Solutions
ADV
$487M
$4.27M 0.04%
16,000
OPI
422
DELISTED
Office Properties Income Trust
OPI
$4.26M 0.04%
156,283
+154,198
+7,396% +$4.76M
CPRX
423
DELISTED
Catalyst Pharmaceutical
CPRX
$4.26M 0.04%
1,105,426
-462,138
-29% -$1.9M
PEP icon
424
PepsiCo
PEP
$188B
$4.26M 0.04%
35,449
-24,638
-41% -$3.33M
DNLI icon
425
Denali Therapeutics
DNLI
$3.8B
$4.24M 0.04%
242,120
+195,743
+422% +$4.08M

Similar funds

Marshall Wace's Q1 2020 Portfolio in Review

As of Q1 2020, Marshall Wace held 2,308 positions worth $10B, down 31% from $14.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace withdrew a net $1.63B in Q1 2020, closing 723 positions and reducing 491 holdings. Its most notable exit was eBay, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Marshall Wace opened a new position in Bank of Montreal worth $53.5M.

  • Marshall Wace's largest Q1 2020 buy was Bank of Montreal: 1,072,183 shares worth $53.5M.
  • Marshall Wace added most to Fidelity National Information Services in Q1 2020, an estimated $146M increase.
  • Marshall Wace's biggest Q1 2020 reduction was Boston Scientific, cutting an estimated $173M.
  • Marshall Wace fully exited eBay in Q1 2020, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 18% of its $10B portfolio in Q1 2020.
  • Marshall Wace opened 654 new positions and closed 723 in Q1 2020.
  • Marshall Wace's portfolio value fell 31% quarter-over-quarter to $10B.

Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.